Snider Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Snider Financial Group's LLY Position: Q3 2026 in Review
Snider Financial Group increased its Eli Lilly (LLY) stake by 0.25% in Q3 2026, buying an estimated $35.4K and bringing the position to 12,158 shares worth $14.1M. The position accounts for 3.39% of the portfolio, ranked #6.
Snider Financial Group first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $14.5M in Q2 2026. 1,444 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Snider Financial Group held 12,158 shares of Eli Lilly worth $14.1M as of Q3 2026.
- Snider Financial Group bought 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
- Eli Lilly made up 3.39% of Snider Financial Group's portfolio in Q3 2026, its #6 holding.
- Snider Financial Group first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
- Snider Financial Group's Eli Lilly position peaked at $14.5M in Q2 2026.
- 1,444 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Snider Financial Group's 13F filing for Q3 2026, filed 16 Oct 2026.